Indian drug major Dr Reddy's Laboratories on Friday announced it would sell Progesterone capsules in the US market for therapeutic treatment of cardiovascular disorders, breast cancer and probable dementia.
"The generic capsules, approved by the US Food and Drug Administration (USFDA), are a therapeutic equivalent version of Prometrium," said the city-based pharma company in a regulatory filing on the BSE.
Prometrium is a registered trademark of Abbvie Products LLC in the US.
"The capsules in 100mg and 200mg will be sold in bottle count size of 100," added the filing.
According to the healthcare industry information, services and technology provider IMS Health, the Prometrium brand and its generic capsules had sales valued at $153 million across the US in 12 months ending February.
--IANS
fb/vd
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app